Evervie Health signs LOI to procure 10 LINAC systems

Business Updates View source PDF Explain this filing

PVP · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-4.8%Reaction day

₹45.52

prior close

₹45.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-2.6%-2.2% vs market

Residential Commercial Projects peers, median of 65sector-2.5%-2.4% vs sector

On the reaction day the stock moved 2.2 pts less than Nifty Microcap 250 and 2.4 pts less than its Residential Commercial Projects peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.0

10m

-0.1

15m

-0.3

30m

-1.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-4.8-2.6-2.2-2.5-2.4

Next day

-9.2-3.6-5.6-3.1-6.2

-12.7-5.8-6.9-5.4-7.3

-8.4-5.5-2.9-5.1-3.3

-3.8pendingpending-3.4-0.4

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Residential Commercial Projects peers, median of 65Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Evervie Health signed a non-binding letter of intent to procure 10 HARMONY linear accelerator systems from Elekta Solutions AB for 11 to 15 million US dollars, payable in Swedish krona. Deliveries are planned in two phases through October 2028 for subsidiary Optimus Oncology. Procurement requires a final agreement, approvals, financing and other conditions.

Likely market impact

The plan may support growth in cancer-care services, but benefits remain uncertain until a binding agreement, approvals and financing are completed.